Lv4
480 积分 2024-05-23 加入
Denosumab withdrawal increases vertebral fracture and mortality risk compared with zoledronate
6小时前
求助中
Clinical experience with denosumab discontinuation
6小时前
待确认
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
18小时前
已完结
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
2天前
已完结
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII
2天前
已完结
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2天前
已完结
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2天前
已完结
Evaluation of fruquintinib’s efficacy and safety in refractory metastatic colorectal cancer: a systematic review and meta-analysis of phase II and III randomized controlled trials
3天前
已完结
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study
3天前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
3天前
已完结
皖公网安备34019202002308
